APA (7th ed.) Citation

BM, T., LF, C., C, S., MS, M., JR, F., FC, G., . . . C, d. C. L. (2022). Pre-treatment MRI tumor features and post-treatment mammographic findings: May they contribute to refining the prediction of pathologic complete response in post-neoadjuvant breast cancer patients with radiologic complete response on MRI? European radiology, 32(3), 1663. https://doi.org/10.1007/s00330-021-08290-1

Chicago Style (17th ed.) Citation

BM, Thompson, Chala LF, Shimizu C, Mano MS, Filassi JR, Geyer FC, Torres US, de Mello GGN, and da Costa Leite C. "Pre-treatment MRI Tumor Features and Post-treatment Mammographic Findings: May They Contribute to Refining the Prediction of Pathologic Complete Response in Post-neoadjuvant Breast Cancer Patients with Radiologic Complete Response on MRI?" European Radiology 32, no. 3 (2022): 1663. https://doi.org/10.1007/s00330-021-08290-1.

MLA (9th ed.) Citation

BM, Thompson, et al. "Pre-treatment MRI Tumor Features and Post-treatment Mammographic Findings: May They Contribute to Refining the Prediction of Pathologic Complete Response in Post-neoadjuvant Breast Cancer Patients with Radiologic Complete Response on MRI?" European Radiology, vol. 32, no. 3, 2022, p. 1663, https://doi.org/10.1007/s00330-021-08290-1.